Partnership to support vaccine formulation across PATH projects

PATH, an international nonprofit global health organization, recently signed an agreement with the University of Kansas Center for Research to support the advancement of vaccine candidates across its vaccine development portfolio.

The KUCR project, under the direction of Dr. Russ Middaugh, will systematically determine how various PATH-supported vaccine candidates behave under a variety of formulation conditions. The goal of the partnership is to characterize vaccine antigens and identify conditions under which their stability may be enhanced.

KUCR has already started working with PATH's pneumococcal vaccine project and will likely work with other PATH vaccine projects in the future.